The
slide to be stained for
human chorionic
gonadotropin (HCG)
comprised:
1.
Placenta (16 weeks), 2.
Seminoma, 3. Embryonal carcinoma, 4.
Choriocarcinoma.
Criteria for assessing a
HCG
staining as optimal included: A strong and distinct cytoplasmic staining of the normal placental
throphoblastic cells, the trophoblastic cells of the choriocarcinoma (scarsely represented in some sections) and the
syncytiotrophoblast like cells of the seminoma, whereas the
neoplastic cells of the seminoma and the embryonal carcinoma should
be negative or only weakly stained.
61 laboratories submitted a HCG staining. At
the assessment 24 achieved optimal staining (39 %), 17 good (28 %),
14 borderline (23 %) and 6 (10 %) poor staining.
The following Abs were used:
pAb A0231 (DakoCytomation; n=55)
pAb 760-2650 (Ventana; n=2)
pAb NCL-HCGp (Novocastra; n=1)
mAb clone 2B1.3 (Immunotech; n=1)
mAb clone ZSH 17 (Zymed; n=1)
In this assessment an optimal staining could
only be obtained with the pAbs A0231 and NCL-HCGp.
Using the pAb A0231 the optimal result could
be obtained both with HIER and proteolytic pre-treatment. The choice
of HIER buffer or proteolytic enzyme had no obvious influence. The
main parameter seemed to be a correct calibrated primary Ab
dilution: In the optimal protocols A0231 was diluted in the range of
1:1.000 – 12.000 using proteolytic pre-treatment and 1:3.000 –
50.000 using HIER.
The pAb NCL-HCGp was used with proteolytic pre-treatment and diluted
1:350.
The listed dilutions were depending on the total sensitivity of the
used protocols.
The prevalent feature of the insufficient
staining was a moderate or strong non-specific staining of especially the neoplastic
cells of the seminoma and the stroma of the placenta (a slight background reaction
in these two specimens was accepted). Only 2
out of 20 protocols giving an insufficient staining revealed
a too weak or false negative reaction. Both these protocols were
without pre-treatment.
The most frequent causes of insufficient
staining were:
- Too high concentration of the primary antibody
- No epitope retrieval
- Inappropriate choice of primary Ab
|